Massive-scale biological activity-based modeling identifies novel antiviral leads against SARS-CoV-2
R. Huang, M. Xu, H. Zhu, C. Z. Chen, E. Lee, S. He, K. Shamim, D. Bougie, W. Huang, M. Hall, D. Lo, A. Simeonov, C. Austin, X. Qiu, H. Tang, W. Zheng
This paper develops a biological activity-based modeling approach to identify novel antiviral compounds against SARS-CoV-2 with high hit rates in live virus assays.
bioRxiv · Jul 27, 2020Cell Biology